PDI, Inc.  

(Public, NASDAQ:PDII)   Watch this stock  
Find more results for Nancy G Sullivan�
+0.07 (4.05%)
Real-time:   11:33AM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.70 - 1.81
52 week 1.34 - 6.25
Open 1.76
Vol / Avg. 16,905.00/123,062.00
Mkt cap 28.14M
P/E     -
Div/yield     -
EPS -0.82
Shares 15.36M
Beta 0.45
Inst. own 47%
Nov 3, 2014
Q3 2014 PDI Inc Earnings Release
Nov 3, 2014
Q3 2014 PDI Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -14.73% -2.99%
Operating margin -14.44% -2.84%
EBITD margin - -1.89%
Return on average assets -28.39% -6.12%
Return on average equity -63.08% -13.26%
Employees 760 -
CDP Score - -


Morris Corporate Center 1 Building A, 300 Interpace Parkway
United States - Map
+1-862-2077800 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


PDI, Inc. provides outsourced commercial services to established and emerging pharmaceutical, biotechnology and healthcare companies in the United States. The Company is a provider of outsourced sales teams that focus on healthcare providers, offering a range of complementary sales support services designed to achieve its customers' strategic and financial product objectives. The Company also offers diagnostic products based on its PathFinderTG platform such as PathfinderTG Pancreas. In addition to outsourced sales teams, it also provides other promotional services, including clinical educator services, digital communications, teledetailing and with the formation of its new business unit, Interpace BioPharma, provides pharmaceutical, biotechnology, medical device and diagnostics clients with full-service product commercialization solutions. The Company has three segments: Sales Services; Marketing Services and Product Commercialization Services (PC Services).

Officers and directors

Gerald P. Belle Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Nancy S. Lurker Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Graham G. Miao Ph.D. Chief Financial Officer, Executive Vice President, Treasurer
Age: 50
Bio & Compensation  - Reuters
Gerald R. Melillo Jr. President - Sales Services
Age: 53
Bio & Compensation  - Reuters
Heiner Dreismann Ph.D. Director
Age: 61
Bio & Compensation  - Reuters
John C. Federspiel Independent Director
Age: 60
Bio & Compensation  - Reuters
Veronica A. Lubatkin CPA Independent Director
Age: 50
Bio & Compensation  - Reuters
Jack E. Stover Independent Director
Age: 61
Bio & Compensation  - Reuters
Stephen J. Sullivan Independent Director
Age: 67
Bio & Compensation  - Reuters